Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grifols Biologicals, Llc

Clinical trials sponsored by Grifols Biologicals, Llc, explained in plain language.

Now part of Grifols, S.A. GRFS NASDAQ

A subsidiary of Grifols, a global plasma-derived medicines company.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Can an immune booster stop serious infections in blood cancer patients?

Prevention Recruiting now

This phase 3 trial is testing whether adding Gamunex-C (an immune globulin) to standard care can prevent serious infections in people with chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma. About 49 participants will receive Gamunex-C through an IV every 4 w…

Phase: PHASE3 • Sponsor: Grifols Biologicals, LLC • Aim: Prevention

Last updated Jun 27, 2026 12:31 UTC